<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Dippel, Diederik W. J.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Resolving Barriers to Intravenous Thrombolysis: Results of the PRACTISE Trial</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">28-29</style></pages><abstract><style  face="normal" font="default" size="100%">In The Netherlands, the rates of thrombolysis for ischemic stroke in are not optimal, despite guidelines recommending its use. This article discusses results from the Promoting Acute Thrombolysis for Ischaemic Stroke [PRACTISE; ISRCTN 20405426] trial, which evaluated the effectiveness of an intensive multifaceted implementation strategy aimed at increasing the number of patients who are treated with thrombolysis.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>